These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 27769294

  • 1. Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.
    Reers S, Agdirlioglu T, Kellner M, Borowski M, Thiele H, Waltenberger J, Reppel M.
    Eur J Med Res; 2016 Oct 21; 21(1):41. PubMed ID: 27769294
    [Abstract] [Full Text] [Related]

  • 2. Comparison of different oral anticoagulant regimens in patients with atrial fibrillation undergoing ablation or cardioversion.
    Gawałko M, Kapłon-Cieślicka A, Budnik M, Babiarz A, Bodys A, Uliński R, Żochowski M, Peller M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G.
    Pol Arch Intern Med; 2017 Dec 22; 127(12):823-831. PubMed ID: 28972957
    [Abstract] [Full Text] [Related]

  • 3. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.
    Giustozzi M, Vedovati MC, Verdecchia P, Pierpaoli L, Verso M, Conti S, Cianella F, Marchesini E, Filippucci E, Agnelli G, Becattini C.
    Eur J Intern Med; 2016 Sep 22; 33():42-6. PubMed ID: 27394924
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, van Eickels M, Cohen A, X-TRA study and CLOT-AF registry investigators.
    Am Heart J; 2016 Aug 22; 178():126-34. PubMed ID: 27502860
    [Abstract] [Full Text] [Related]

  • 7. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E, Anselmino M, Zorzi A, Russo V, Toso E, Peruzza F, Rapacciuolo A, Migliore F, Gaita F, Cucchini U, De Divitiis M, Iliceto S, Stabile G.
    Int J Cardiol; 2017 Dec 15; 249():179-183. PubMed ID: 29121724
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G, Billionnet C, Alla F, Gagne JJ, Pariente A.
    Pharmacotherapy; 2018 Jan 15; 38(1):6-18. PubMed ID: 29028119
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI, Sayers M, Lip GY, Lane DA.
    Int J Clin Pract; 2015 Nov 15; 69(11):1341-8. PubMed ID: 26234557
    [Abstract] [Full Text] [Related]

  • 13. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M, Gabriels J, Khan M, Shaban N, D'Amato S, Liu CF, Markowitz SM, Ip JE, Thomas G, Singh P, Lerman B, Patel A, Cheung JW.
    Heart Rhythm; 2018 Apr 15; 15(4):496-502. PubMed ID: 29605015
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants.
    Angelini F, Bocchino PP, Peyracchia M, Saglietto A, Magnano M, Patanè N, D'Ascenzo F, Giustetto C, Anselmino M, Gaita F, Toso E.
    Acta Cardiol; 2023 May 15; 78(3):290-297. PubMed ID: 34821203
    [Abstract] [Full Text] [Related]

  • 16. Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists.
    Sørensen R, Jamie Nielsen B, Langtved Pallisgaard J, Ji-Young Lee C, Torp-Pedersen C.
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul 01; 3(3):151-156. PubMed ID: 28158553
    [Abstract] [Full Text] [Related]

  • 17. Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.
    Collings SL, Lefèvre C, Johnson ME, Evans D, Hack G, Stynes G, Maguire A.
    PLoS One; 2017 Jul 01; 12(10):e0185642. PubMed ID: 29016695
    [Abstract] [Full Text] [Related]

  • 18. Left atrial appendage thrombus in patients with atrial fibrillation who underwent oral anticoagulation.
    Karwowski J, Rekosz J, Mączyńska-Mazuruk R, Wiktorska A, Wrzosek K, Loska W, Szmarowska K, Solecki M, Sumińska-Syska J, Dłużniewski M.
    Cardiol J; 2024 Jul 01; 31(3):461-471. PubMed ID: 35703043
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation.
    Vinding NE, Bonde AN, Rørth R, Lamberts M, Olesen JB, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL.
    Europace; 2019 Apr 01; 21(4):572-580. PubMed ID: 30508073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.